prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumA, PATIENT HISTORY: The patient is a. year-old woman with a core biopsy in. showing infiltrating ductal carcinoma, mucinous type,. nuclear grade 1 (ER and PR positive, and HER-2/neu negative). PRE-OP DIAGNOSIS: Right breast cancer; postmenopausal bleeding. POST-OP DIAGNOSIS: Same. PROCEDURE: Right total mastectomy, sentinel node biopsy, hysteroscopy, D&C. FINAL DIAGNOSIS: PART 1: BREAST/RIGHT, TOTAL MASTECTOMY -. A. MULTIFOCAL INFILTRATING DUCTAL CARCINOMA, MUCINOUS TYPE, INVOLVING THELOWER INNER. QUADRANT. B. THE TWO FOCI OF INVASIVE CARCINOMA ARE BOTH 1.5 CM IN GREATEST DIMENSION. C. NOTTINGHAM SCORE 4 (TUBULE FORMATION, 2; NUCLEAR PLEOMORPHISM, 1; MITOTIC INDEX 1). D. DUCTAL CARCINOMA IN SITU (DCIS), SOLID TYPE, NUCLEAR GRADE 1. E. DCIS CONSTITUTES APPROXIMATELY 15% OF THE TUMOR MASS. F. NO ANGIOLYMPHATIC INVASION IS IDENTIFIED. G. SURGICAL MARGINS FREE OF CARCINOMA. H. PREVIOUS BIOPSY SITE IS IDENTIFIED. I. BENIGN BREAST TISSUE. J. SKIN AND NIPPLE NOT REMARKABLE. K. ONE LYMPH NODE NEGATIVE FOR CARCINOMA (0/1). PART 2: RIGHT AXILLA, SENTINEL LYMPH NODE#1, BIOPSY -. ONE LYMPH NODE NEGATIVE FOR MALIGNANCY (0/1). PART 3: ENDOCERVIX, CURETTAGE -. A. RARE BENIGN ENDOCERVICAL CELLS AND MUCUS,. B. NEGATIVE FOR ATYPIA OR CARCINOMA. PART 4: ENDOMETRIUM, CURETTAGE -. A. SCANT BENING ENDOMETRIUM WITH MUCUS AND CELL DEBRIES (Cross refer. B. NEGATIVE FOR ATYPIA OR CARCINOMA. COMMENT: Estrogen and progesterone receptors and HER2/neu, performed on the previous core biopsy. were. reported as follows: ER positive, PR positive, HER-2/neu negative (score 1+).

expanded version (tokens=950) : 
 The patient is a postmenopausal woman with Luminal A subtype of breast cancer with infiltrating ductal carcinoma, mucinous type, and nuclear grade 1. The tumor is ER and PR positive and HER-2/neu negative. The final diagnosis indicates multifocal invasive ductal carcinoma, mucinous type, totaling 3 cm in size, with no angiolymphatic invasion identified. Approximately 15% of the tumor mass consists of ductal carcinoma in situ (DCIS) of the solid type with nuclear grade 1. The Nottingam score is 4, with tubule formation grade 2, nuclear pleomorphism grade 1, and mitotic index grade 1. The lymph node and surgical margins show no evidence of carcinoma. The biopsy of sentinel lymph node #1 in the right axilla also shows no malignancy. Estrogen and progesterone receptors are positive, and HER-2/neu is negative (score 1+).

Additional information about the report includes that the patient had a previous core biopsy in which cancer was diagnosed. The patient underwent a total mastectomy, sentinel node biopsy, hysteroscopy, and D&C. Benign tissue was also identified in the breast. Endocervix and endometrium curettage tests both turned negative for atypia or carcinoma. No mention of tumor infiltrating lymphocytes or calcification was reported, and no other ancillary testing results were mentioned.

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1131) : 
 Postmenopausal woman diagnosed with Luminal A subtype breast cancer, invasive ductal carcinoma with mucinous type and nuclear grade 1, ER/PR positive and HER-2/neu negative. Reports multifocal tumors totaling 3cm without angiolymphatic invasion or calcification. Approximately 15% tumor mass is solid DCIS of nuclear grade 1. No malignancy in any lymph node biopsies taken. Surgical margins free of carcinoma. Estrogen and progesterone receptor positive and HER-2/neu negative (score 1+). No atypia or carcinoma in endocervix or endometrium curettage testing.

